Valuation: Formycon AG

Market Cap 313M 358M 289M 266M 501M 34.47B 513M 3.45B 1.36B 16.88B 1.34B 1.31B 58.12B P/E 2026 *
-29.1x
P/E 2027 * 10x
Enterprise Value 382M 437M 352M 325M 612M 42.08B 626M 4.21B 1.66B 20.61B 1.64B 1.6B 70.94B EV / Sales 2026 *
5.25x
EV / Sales 2027 * 3.52x
Free-Float
70%
Yield 2026 *
-
Yield 2027 * -
1 day+2.66%
1 week-0.11%
Current month-7.92%
1 month-7.45%
3 months-4.43%
6 months-21.30%
Current year-29.14%
1 week 17.68
Extreme 17.68
18.6
1 month 17.68
Extreme 17.68
20.35
Current year 15.8
Extreme 15.8
26.95
1 year 15.8
Extreme 15.8
31.3
3 years 15.8
Extreme 15.8
69.6
5 years 15.8
Extreme 15.8
94.1
10 years 14.65
Extreme 14.65
94.1
Manager TitleAgeSince
Chief Executive Officer - 01/07/2022
Director of Finance/CFO 57 01/04/2023
Chief Tech/Sci/R&D Officer - 01/07/2022
Director TitleAgeSince
Director/Board Member 49 10/12/2020
Chairman 54 12/06/2024
Director/Board Member 54 12/06/2024
Date Insider Type Main position Quantity % Market Cap.
21/02/25 Buy

Chief Technology Officer

160 0.0009%
29/04/24 Buy

Executive/Senior Manager

1,200 0.0068%
24/04/24 Buy

Chief Executive Officer

2,500 0.0142%
Change 5-day change 1-year change 3-year change Capi.($)
+2.66%-0.11%-37.66%-71.57% 358M
-0.12%-3.74%+0.89%+2.57% 49.18B
+3.90%-0.39%+386.06%+588.97% 39.58B
-1.70%+4.46%+5.93%+61.54% 34.69B
-2.01%-0.76%+28.41%-8.52% 34.42B
+0.06%+0.34%+2.38%+34.47% 27.11B
+0.46%-3.49% - - 16.21B
-0.04%-0.09%+72.42%+116.45% 15.36B
+0.80%+1.99%+15.10%+17.90% 14.05B
0.00%+1.36%+18.43%-31.23% 13.02B
Average +0.41%-0.56%+54.66%+78.95% 24.4B
Weighted average by Cap. +0.17%-0.19%+79.56%+122.14%

Financials

2026 *2027 *
Net sales 72.73M 83.23M 67.12M 61.87M 117M 8.02B 119M 802M 316M 3.93B 313M 306M 13.51B 121M 139M 112M 103M 195M 13.37B 199M 1.34B 526M 6.55B 522M 510M 22.55B
Net income -10.92M -12.5M -10.08M -9.29M -17.51M -1.2B -17.9M -120M -47.38M -589M -46.93M -45.9M -2.03B 30.87M 35.32M 28.48M 26.26M 49.49M 3.4B 50.59M 340M 134M 1.67B 133M 130M 5.74B
Net Debt 69.04M 79M 63.71M 58.72M 111M 7.61B 113M 761M 300M 3.73B 297M 290M 12.83B 115M 131M 106M 97.73M 184M 12.66B 188M 1.27B 498M 6.2B 494M 483M 21.35B
Logo Formycon AG
Formycon AG is a Germany based Company. The Company is engaged in providing biosimilar drugs and formulations. The Company focuses on treatments in ophthalmology, immunology and other chronic diseases, covering all steps of biosimilar development process, from early-stage analysis of the originator drug to the preclinical and clinical testing phases, as well as the preparation of dossiers for marketing approval.
Employees
203
Date Price Change Volume
20/07/26 18.14 +2.49% 831
17/07/26 €17.70 -1.34% 5,258
16/07/26 €17.94 -1.21% 8,993
15/07/26 €18.16 -0.55% 824
14/07/26 €18.26 +0.55% 4,315
Trader
Investor
-
Global
-
Quality
ESG MSCI
B
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
7
Last Close Price
17.70EUR
Average target price
39.67EUR
Spread / Average Target
+124.11%

Quarterly revenue - Rate of surprise